✦ LIBER ✦

Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors

✍ Scribed by Sylvie Perachon; Jean-Charles Schwartz; Pierre Sokoloff

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Functional potencies of dopamine agonist

✍ Yoshihiro Tadori; Robert A. Forbes; Robert D. McQuade; Tetsuro Kikuchi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 625 KB

Relative affinities of dopaminergic drug

✍ Beth Levant; Dimitri E. Grigoriadis; Errol B. De Souza 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 708 KB

Actions of roxindole at recombinant huma

✍ A. Newman-Tancredi; D. Cussac; V. Audinot; M. J. Millan 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 97 KB

Comparison of the functional potencies o

✍ Martyn C Coldwell; Izzy Boyfield; Tony Brown; Jim J Hagan; Derek N Middlemiss 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 229 KB

Differential induction of adenylyl cycla

✍ Gabriella Aloisi; Elena Silvano; Mario Rossi; Mark J. Millan; Roberto Maggio 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 450 KB

Novel Mechanisms of Drug Action: Functio

✍ Richard B. Mailman; Elaine A. Gay 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 601 KB